FMR CORP 13D/13G Filings for Evelo Biosciences, Inc. (EVLO)

FMR CORP 13D and 13G filings for Evelo Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-06-12
08:21 am
Sale		 2023-06-09 13G Evelo Biosciences, Inc.
EVLO		 FMR CORP 489,782
8.746%		 -331,635decrease
(-40.37%)		 Filing
2023-02-09
10:59 am
Purchase		 2023-02-09 13G Evelo Biosciences, Inc.
EVLO		 FMR CORP 821,418
14.987%		 420,468increase
(+104.87%)		 Filing
2022-02-09
09:11 am
Purchase		 2022-02-08 13G Evelo Biosciences, Inc.
EVLO		 FMR CORP 400,950
14.999%		 60,781increase
(+17.87%)		 Filing
2021-02-08
10:21 am
Purchase		 2021-02-05 13G Evelo Biosciences, Inc.
EVLO		 FMR CORP 340,168
14.729%		 178,047increase
(+109.82%)		 Filing